04.01.2011Medtech Investing Europe Conference - LausanneYou are hereEventsBioAlps eventsMedtech Investing Europe Conference - Lausanne
7th & 8th March 2011
Beaulieu Exploitation SA, Lausanne, Switzerland
Europe’s premier investment partnering event
The 12th Medtech Investing Europe Conference is a leading event in Europe showcasing cutting-edge medical technology and latest opportunities for investors as well as addressing the most pressing issues for the medtech sphere.
Now in its 12th edition, MedTech Investing Europe will once again deliver the perfect mixture of start-ups presentations, one-to-one meetings and keynote sessions.
Over 40 start-ups will be presenting their latest innovation including: Abionic SA, Aleva Neurotherapeuties, Anagnostics BioAnalysis, Arterion AB, Augurix Diagnostics, BiancaMed Ltd, Calon Cardio Technology, CeQur SA, Degonda Rehab SA, Edel Therapeutics, ElMindA Ltd, Endosense, Erib Corp, ExCellness Biotech SA, Imagine Eyes, Inomed Technology, Lombard Medical Techologies PLC, MindMaze, MediMaps, MyoPowers Technology, StereoTools SA, Tigran Technologies AB, Viroblock and more will be confirmed soon.
Senior executives from Medtronic, Philips, Baxter Healthcare, Johnson & Johnson, Smith & Nephew will be speaking alongside senior officials of the European Investment Bank, European Commission as well as some of the most experienced medtech entrepreneurs, venture capitalists and regulatory experts.
Produced in partnership with École Polytechnique Fédérale de Lausanne and with the invaluable support of Canton Vaud, this event will bring together industry leaders from across the world.
Attendance for this event is primarily focused at the investor community and major healthcare corporations.
SPECIAL OFFER: 20% discount on the delegate fees for all BioAlps clients. To book your place please contact barbara.benhamadi[at]bioalps.org
For a complete programme, information about presenting companies, please visit www.medtechinvesting.com.
To the members of our network:
Do not hesitate to if you need more information about the possible opportunity to benefit from advantageous registration conditions.